Marcela Viviana Karpuj

Prof. Marcela Viviana Karpuj

orcid

Biography

Throughout my career, I have been deeply committed to elucidating the complexities of neurodegenerative disorders and focusing on translational medicine. My journey has been a testament to my dedication to understanding these diseases and developing innovative therapeutic solutions that can genuinely improve the lives of patients. During my Ph.D. at the Weizmann Institute, I embarked on a remarkable research journey focused on Huntington's Disease. It was here that I made a groundbreaking discovery—a novel pathway involving the enzyme transglutaminase that plays a crucial role in the disease1. This discovery ignited a series of preclinical trials at Stanford University, where the enzyme inhibitor cysteamine emerged as a promising candidate2. This progress eventually advanced to phase 2/3 clinical trials, offering tangible hope for patients, and inspiring me to continue my pursuit. My passion for innovation led me to the laboratory of Nobel Laureate Professor Stanley Prusiner, where I delved into the enigmatic world of prion diseases. There, I conducted pioneering research that demonstrated the potential of Phosphorothioate oligonucleotides (PSDNA) to eliminate prion infectivity in cell culture—a breakthrough subsequently validated in a prion animal model3. This research paved the way for new approaches to treating prion diseases, offering a glimmer of hope in combatting this lethal condition. Setting up my laboratory at the Faculty of Agriculture, I secured competitive grant

Affiliations

No affiliation has been shared yet.

Honors and Awards

No honors or awards have been shared yet.

Experience

No experience has been shared yet.